Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 31 most recent Form 4 transactions.
| $26.1K |
| -0.5% |
| Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,900 | $63.69 | $121K | -2.1% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 20,735 | $62.61 | $1.3M | -18.8% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 27,473 | $62.00 | $1.7M | -19.9% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 20,000 | $17.44 | $348.8K | +17.0% | Open the original filing on SEC.gov |
| May 6 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 310 | $43.95 | $13.6K | -0.3% | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 2,181 | $46.65 | $101.7K | -1.8% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,250 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 8,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,250 | — | — | +3.6% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,014 | $42.61 | $43.2K | -0.9% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 7,239 | $41.93 | $303.5K | -5.8% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 9 | $41.07 | $370 | <0.1% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 65 | $28.85 | $1.9K | <0.1% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 14,000 | — | — | +12.6% | Open the original filing on SEC.gov |
| Feb 4 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 110 | $32.90 | $3.6K | -0.1% | Open the original filing on SEC.gov |
| Feb 4 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,635 | $32.14 | $52.5K | -1.5% | Open the original filing on SEC.gov |
| Feb 3 | TVTX | Travere Therapeutics, Inc. | SSELL | 7,242 | $32.12 | $232.6K | -6.0% | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 75,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT | 28,130 | — | — | +30.6% | Open the original filing on SEC.gov |
| Dec 1, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 1, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 20,000 | $35.01 | $700.2K | -17.8% | Open the original filing on SEC.gov |
| Dec 1, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 20,000 | $16.23 | $324.6K | +21.7% | Open the original filing on SEC.gov |
| Sep 4, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 119 | $19.71 | $2.3K | -0.1% | Open the original filing on SEC.gov |
| Sep 3, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 454 | $18.20 | $8.3K | -0.5% | Open the original filing on SEC.gov |
| Aug 27, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 470 | $17.31 | $8.1K | -0.5% | Open the original filing on SEC.gov |
| May 5, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL | 1,784 | $21.05 | $37.6K | -1.9% | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◆ | 4,920 | — | — | — | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER | 4,920 | — | — | +5.5% | Open the original filing on SEC.gov |
| Apr 11, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL | 48 | $13.14 | $631 | <0.1% | Open the original filing on SEC.gov |